Enact (ACT) Stock Insights
$6.57B
Market Cap
10.12
P/E
9.91
Forward P/E
53
Score
ACT price $47.80 -0.27 -0.56%
Stocklytics score rationale: value 51, quality 74, growth 34.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 841097000 | 978853000 | 1106459000 | 1120185000 | 1094873000 | 1153686000 | 1201932000 | 1230382000 |
Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company engages in writing and assuming residential mortgage guaranty insurance. It also offers private mortgage insurance products insuring prime-based, individually underwritten residential mortgage loans; pool mortgage insurance; contract underwriting services; and mortgage-related reinsurance products. The company…
ACT fair value Not meaningful. Price $47.80.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
No estimate. Cash-flow models don't suit banks
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 1.19 | — | 317.92M |
| 2026-08-05 | 1.26 | 1.19 | 317.31M | 315.81M |
| 2026-05-05 | 1.21 | 1.21 | 312.07M | 314.91M |
| 2026-02-03 | 1.23 | 1.09 | 312.71M | 317.02M |
| 2025-11-05 | 1.12 | 1.12 | 311.45M | 315.62M |
| 2025-07-30 | 1.15 | 1.11 | 304.62M | 310.26M |
| 2025-04-30 | 1.10 | 1.12 | 306.89M | 302.24M |
| 2025-02-04 | 1.09 | 1.02 | 301.78M | 309.30M |
| 2024-11-06 | 1.15 | 1.00 | 309.59M | 305.79M |
| 2024-07-31 | 1.27 | 0.99 | 298.83M | 299.40M |
| 2024-05-01 | 1.04 | 0.96 | 291.59M | 294.12M |
| 2024-02-06 | 0.98 | 0.92 | 296.19M | 297.41M |
| 2023-11-01 | 1.02 | 0.89 | 299.04M | 291.40M |
| 2023-08-01 | 1.04 | 0.84 | 277.52M | 289.57M |
| 2023-05-03 | 1.08 | 0.80 | 280.94M | 283.66M |
| 2023-02-06 | 0.88 | 0.84 | 276.67M | 272.53M |
| 2022-11-01 | 1.17 | 0.87 | 275.07M | 238.05M |
| 2022-08-01 | 1.25 | 0.86 | 273.54M | 235.93M |
| 2022-05-03 | 1.01 | 0.84 | 269.59M | 272.33M |
| 2022-02-01 | 0.94 | 0.83 | 272.88M | 279.53M |
| 2021-11-02 | 0.84 | 0.81 | 280.31M | 266.42M |
| 2021-09-17 | 0.80 | — | 276.12M | — |
| 2021-03-31 | 0.77 | — | 289.44M | — |
| 2020-12-31 | 0.56 | — | 285.51M | — |
| 2020-09-30 | 0.85 | — | 284.34M | — |
| 2020-06-30 | -0.02 | — | 276.03M | — |
| 2020-03-31 | 0.89 | — | 260.58M | — |
| 2019-12-31 | 1.17 | — | 269.49M | — |
| 2019-09-30 | 1.12 | — | 250.68M | — |
| 2019-06-30 | 0.94 | — | 229.34M | — |
| 2019-03-31 | 0.94 | — | 229.34M | — |
Yield 1.88%. Payout ratio 18.22%. Frequency Quarterly.
Safety score 80/100 · Safe. Payout ratio is 18% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 6 separate years. Yield is 1.9%, in a range that is usually sustainable.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-08-20 | $0.24 | 2026-08-20 | 2026-09-17 | Quarterly |
| 2026-05-28 | $0.24 | 2026-05-28 | 2026-06-18 | Quarterly |
| 2026-02-26 | $0.21 | 2026-02-26 | 2026-03-19 | Quarterly |
| 2025-11-21 | $0.21 | 2025-11-21 | 2025-12-11 | Quarterly |
| 2025-08-18 | $0.21 | 2025-08-18 | 2025-09-08 | Quarterly |
| 2025-05-19 | $0.21 | 2025-05-19 | 2025-06-11 | Quarterly |
| 2025-02-21 | $0.18 | 2025-02-21 | 2025-03-14 | Quarterly |
| 2024-11-18 | $0.18 | 2024-11-18 | 2024-12-05 | Quarterly |
| 2024-08-28 | $0.18 | 2024-08-28 | 2024-09-09 | Quarterly |
| 2024-05-29 | $0.18 | 2024-05-29 | 2024-06-13 | Quarterly |
| 2024-02-27 | $0.16 | 2024-02-28 | 2024-03-13 | Semi-Annual |
| 2023-11-15 | $0.87 | 2023-11-16 | 2023-12-05 | Special |
| 2023-08-30 | $0.16 | 2023-08-31 | 2023-09-13 | Quarterly |
| 2023-05-30 | $0.16 | 2023-05-31 | 2023-06-14 | Quarterly |
| 2023-02-22 | $0.14 | 2023-02-23 | 2023-03-09 | Semi-Annual |
| 2022-11-17 | $1.26 | 2022-11-18 | 2022-12-06 | Special |
| 2022-08-25 | $0.14 | 2022-08-26 | 2022-09-09 | Quarterly |
| 2022-05-06 | $0.14 | 2022-05-09 | 2022-05-26 | Irregular |
| 2021-11-24 | $1.23 | 2021-11-26 | 2021-12-15 | Special |
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | McMullen James | Buy | 887 | — | — |
| 2026-10-01 | McMullen James | Sell | 253 | $44.15 | 11.17K |
| 2026-10-01 | McMullen James | Sell | 887 | — | — |
| 2026-09-30 | Genworth Holdings, Inc. | Sell | 762.89K | $48.65 | 37.12M |
| 2026-09-17 | RESTREPO ROBERT P JR | Buy | 177 | — | — |
| 2026-09-17 | Addesso Dominic James | Buy | 308 | — | — |
| 2026-09-17 | Mitchell Hardin Dean | Buy | 66 | — | — |
| 2026-09-17 | Mitchell Hardin Dean | Buy | 51 | — | — |
| 2026-09-17 | Mitchell Hardin Dean | Buy | 32 | — | — |
| 2026-09-17 | STILL DEBRA | Buy | 177 | — | — |
| 2026-09-17 | Gupta Rohit | Buy | 191 | — | — |
| 2026-09-17 | Gupta Rohit | Buy | 153 | — | — |
| 2026-09-17 | Gupta Rohit | Buy | 94 | — | — |
| 2026-09-17 | Hooda Sheila | Buy | 177 | — | — |
| 2026-09-17 | Mitchell H Elizabeth | Buy | 50 | — | — |
| 2026-09-17 | Derstine Michael | Buy | 35 | — | — |
| 2026-09-17 | Derstine Michael | Buy | 21 | — | — |
| 2026-09-17 | Derstine Michael | Buy | 13 | — | — |
| 2026-09-17 | THOMPSON WESTLEY V | Buy | 177 | — | — |
| 2026-09-17 | FISK JOHN D | Buy | 177 | — | — |
| 2026-09-17 | Gould Brian | Buy | 20 | — | — |
| 2026-09-17 | Gould Brian | Buy | 17 | — | — |
| 2026-09-17 | Gould Brian | Buy | 10 | — | — |
| 2026-09-17 | BLESS MICHAEL A | Buy | 156 | — | — |
| 2026-09-17 | Stolove Evan | Buy | 25 | — | — |
| 2026-09-17 | Stolove Evan | Buy | 21 | — | — |
| 2026-09-17 | Stolove Evan | Buy | 13 | — | — |
| 2026-09-17 | McMullen James | Buy | 14 | — | — |
| 2026-09-17 | McMullen James | Buy | 9 | — | — |
| 2026-09-17 | McMullen James | Buy | 7 | — | — |
| 2026-09-17 | McMullen James | Buy | 5 | — | — |
| 2026-09-17 | McMullen James | Buy | 3 | — | — |
| 2026-08-31 | Genworth Holdings, Inc. | Sell | 687.38K | $49.40 | 33.95M |
| 2026-08-17 | Stolove Evan | Sell | 20.02K | $49.52 | 991.67K |
| 2026-07-31 | Genworth Holdings, Inc. | Sell | 523.23K | $45.92 | 24.03M |
| 2026-06-30 | Genworth Holdings, Inc. | Sell | 605.07K | $42.28 | 25.58M |
| 2026-06-18 | Gould Brian | Buy | 23 | — | — |
| 2026-06-18 | Gould Brian | Buy | 19 | — | — |
| 2026-06-18 | Gould Brian | Buy | 12 | — | — |
| 2026-06-18 | BLESS MICHAEL A | Buy | 176 | — | — |
| 2026-06-18 | STILL DEBRA | Buy | 201 | — | — |
| 2026-06-18 | Hooda Sheila | Buy | 201 | — | — |
| 2026-06-18 | Addesso Dominic James | Buy | 348 | — | — |
| 2026-06-18 | Stolove Evan | Buy | 28 | — | — |
| 2026-06-18 | Stolove Evan | Buy | 24 | — | — |
| 2026-06-18 | Stolove Evan | Buy | 15 | — | — |
| 2026-06-18 | Mitchell H Elizabeth | Buy | 56 | — | — |
| 2026-06-18 | Mitchell Hardin Dean | Buy | 75 | — | — |
| 2026-06-18 | Mitchell Hardin Dean | Buy | 58 | — | — |
| 2026-06-18 | Mitchell Hardin Dean | Buy | 36 | — | — |
| 2026-06-18 | Gupta Rohit | Buy | 217 | — | — |
| 2026-06-18 | Gupta Rohit | Buy | 173 | — | — |
| 2026-06-18 | Gupta Rohit | Buy | 107 | — | — |
| 2026-06-18 | RESTREPO ROBERT P JR | Buy | 201 | — | — |
| 2026-06-18 | Derstine Michael | Buy | 39 | — | — |
| 2026-06-18 | Derstine Michael | Buy | 24 | — | — |
| 2026-06-18 | Derstine Michael | Buy | 15 | — | — |
| 2026-06-18 | FISK JOHN D | Buy | 201 | — | — |
| 2026-06-18 | THOMPSON WESTLEY V | Buy | 201 | — | — |
| 2026-06-18 | McMullen James | Buy | 15 | — | — |
| 2026-06-18 | McMullen James | Buy | 10 | — | — |
| 2026-06-18 | McMullen James | Buy | 8 | — | — |
| 2026-06-18 | McMullen James | Buy | 5 | — | — |
| 2026-06-18 | McMullen James | Buy | 4 | — | — |
| 2026-06-03 | Addesso Dominic James | Buy | 9.29K | — | — |
| 2026-06-03 | Addesso Dominic James | Sell | 9.29K | — | — |
| 2026-05-29 | Genworth Holdings, Inc. | Sell | 602.44K | $42.91 | 25.85M |
| 2026-05-13 | Mitchell H Elizabeth | Buy | 3.94K | — | — |
| 2026-05-13 | Hooda Sheila | Buy | 3.94K | — | — |
| 2026-05-13 | THOMPSON WESTLEY V | Buy | 3.94K | — | — |
| 2026-05-13 | STILL DEBRA | Buy | 3.94K | — | — |
| 2026-05-13 | Addesso Dominic James | Buy | 6.72K | — | — |
| 2026-05-13 | FISK JOHN D | Buy | 3.94K | — | — |
| 2026-05-13 | BLESS MICHAEL A | Buy | 3.94K | — | — |
| 2026-05-13 | RESTREPO ROBERT P JR | Buy | 3.94K | — | — |
| 2026-04-30 | Genworth Holdings, Inc. | Sell | 560.45K | $42.55 | 23.85M |
| 2026-04-01 | McMullen James | Buy | 594 | — | — |
| 2026-04-01 | McMullen James | Sell | 169 | $40.57 | 6.86K |
| 2026-04-01 | McMullen James | Sell | 594 | — | — |
| 2026-03-31 | Genworth Holdings, Inc. | Sell | 820.57K | $40.92 | 33.58M |
| 2026-03-19 | Gould Brian | Buy | 21 | — | — |
| 2026-03-19 | Gould Brian | Buy | 17 | — | — |
| 2026-03-19 | Gould Brian | Buy | 11 | — | — |
| 2026-03-19 | Hooda Sheila | Buy | 162 | — | — |
| 2026-03-19 | Gupta Rohit | Buy | 197 | — | — |
| 2026-03-19 | Gupta Rohit | Buy | 158 | — | — |
| 2026-03-19 | Gupta Rohit | Buy | 97 | — | — |
| 2026-03-19 | Mitchell Hardin Dean | Buy | 69 | — | — |
| 2026-03-19 | Mitchell Hardin Dean | Buy | 53 | — | — |
| 2026-03-19 | Mitchell Hardin Dean | Buy | 33 | — | — |
| 2026-03-19 | McMullen James | Buy | 14 | — | — |
| 2026-03-19 | McMullen James | Buy | 9 | — | — |
| 2026-03-19 | McMullen James | Buy | 8 | — | — |
| 2026-03-19 | McMullen James | Buy | 7 | — | — |
| 2026-03-19 | McMullen James | Buy | 5 | — | — |
| 2026-03-19 | FISK JOHN D | Buy | 162 | — | — |
| 2026-03-19 | RESTREPO ROBERT P JR | Buy | 162 | — | — |
| 2026-03-19 | STILL DEBRA | Buy | 162 | — | — |
| 2026-03-19 | Derstine Michael | Buy | 36 | — | — |
| 2026-03-19 | Derstine Michael | Buy | 21 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 251, holders -3 vs prior quarter. Ownership 21.57%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 4.78M | 115.82K | +2.48% | 218.53M |
| DIMENSIONAL FUND ADVISORS LP | 3.11M | 105.73K | +3.52% | 142.09M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.76M | 17.82K | +1.02% | 80.39M |
| FIRST TRUST ADVISORS LP | 1.62M | 227.52K | +16.31% | 74.17M |
| GLENDON CAPITAL MANAGEMENT LP | 1.30M | 0 | 0.00% | 59.36M |
| STATE STREET CORP | 1.26M | 52.12K | +4.32% | 57.51M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.25M | -47.90K | -3.70% | 57.03M |
| LSV ASSET MANAGEMENT | 1.01M | -20.30K | -1.98% | 45.95M |
| AMERICAN CENTURY COMPANIES INC | 965.68K | 89.08K | +10.16% | 44.14M |
| GEODE CAPITAL MANAGEMENT, LLC | 900.99K | 26.67K | +3.05% | 41.19M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 877.58K | -115.41K | -11.62% | 40.11M |
| MORGAN STANLEY | 555.88K | 41.34K | +8.04% | 25.41M |
| INVESCO LTD. | 509.40K | 43.72K | +9.39% | 23.28M |
| BANK OF NEW YORK MELLON CORP | 403.05K | 982 | +0.24% | 18.42M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 398.30K | 398.30K | New | 18.21M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 398.30K | 6.20K | +1.58% | 18.21M |
| ALLIANZ ASSET MANAGEMENT GMBH | 379.29K | -181.48K | -32.36% | 17.34M |
| GOLDMAN SACHS GROUP INC | 363.37K | 21.47K | +6.28% | 16.61M |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 316.86K | -25.03K | -7.32% | 14.48M |
| NORTHERN TRUST CORP | 315.85K | 12.81K | +4.23% | 14.44M |
| ROYCE & ASSOCIATES LP | 307.13K | 44.84K | +17.09% | 14.04M |
| TWO SIGMA INVESTMENTS, LP | 275.03K | -229.47K | -45.48% | 12.57M |
| EDGESTREAM PARTNERS, L.P. | 250.97K | 45.59K | +22.20% | 11.47M |
| PRUDENTIAL FINANCIAL INC | 249.77K | -84.78K | -25.34% | 11.42M |
| AQR CAPITAL MANAGEMENT LLC | 240.38K | 10.66K | +4.64% | 10.99M |
| Period | Value |
|---|---|
| Q4 2010 | Anti-infective agents: 161500000.0, Cardiovascular: 594600000.0, Central nervous system: 907600000.0, Hormones and synthetic substitutes: 682300000.0, Others: 942600000.0, Urology: 127300000.0 |
| Q1 2011 | Distribution segment: 179500000.0, Global Brands Contribution Member: 80300000.0, Global Generics segment: 585000000.0 |
| Q2 2011 | Distribution segment: 176400000.0, Global Brands Contribution Member: 20900000.0, Global Generics segment: 10900000.0 |
| Q3 2011 | Distribution segment: 168800000.0, Global Brands Contribution: 17800000.0, Global Generics segment: 10100000.0 |
| Q4 2011 | Distribution segment: 251400000.0, Global Brands Contribution: 20800000.0, Global Generics segment: 10900000.0 |
| Q1 2012 | Distribution segment: 298600000.0, Global Brands Contribution: 16700000.0, Global Generics segment: 8100000.0 |
| Q2 2012 | Distribution segment: 240900000.0, Global Brands Contribution: 18400000.0, Global Generics segment: 19000000.0 |
| Q3 2012 | Distribution Segment: 243000000.0, Global Brands Contribution: 16100000.0, Global Generics Segment: 8400000.0 |
| Q4 2012 | Anti Infective Agents: 267900000.0, Cardiovascular: 1298500000.0, Central Nervous System: 1964000000.0, Hormones And Synthetic Substitutes: 868500000.0, Others: 1210300000.0, Urology: 174000000.0 |
| Q1 2013 | Actavis Pharma Segment: 9700000.0, Actavis Specialty Brands Segment: 14500000.0, Anda Distribution Segment: 231000000.0 |
| Q2 2013 | Actavis Pharma Segment: 43700000.0, Actavis Specialty Brands Segment: 17900000.0, Anda Distribution Segment: 275800000.0 |
| Q3 2013 | Actavis Pharma Segment: 24900000.0, Actavis Specialty Brands Segment: 16100000.0, Anda Distribution Segment: 307100000.0 |
| Period | Value |
|---|---|
| Q4 2012 | United States: 4718800000.0 |
Insights · Dividends · Forecast · Financials · Learn
$6.57B
Market Cap
10.12
P/E
9.91
Forward P/E
53
Score